1. Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients
2. Sunscreen drug products for over‐the‐counter human use: proposed rule;US Food and Drug Administration (FDA);Fed Regist,2019
3. European Commission. Scientific Committee on Consumer Safety.Opinion on 4‐methylbenzylidene camphor. SCCP/1042/06. Available at:https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_075.pdf(last accessed 11 December 2019).
4. European Commission. Scientific Committee on Consumer Safety.Opinion on 2‐(4‐(2‐(4‐diethylamino‐2‐hydroxy‐benzoyl)‐benzoyl)‐piperazine‐1‐carbonyl)‐phenyl)‐(4‐diethylamino‐2‐hydroxyphenyl)‐methanone HAA299 as UV filter in sunscreen products. SCCS/1533/14. Available at:https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_159.pdf(last accessed 11 December 2019).
5. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials